Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,166.9
-13.7 (-0.43%)

 

  • STI Straits Times Index
    3,166.9
    -13.7 (-0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,494.6
    -18.3 (-1.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,961.0
    -354.3 (-1.35%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,397.4
    -14.4 (-0.42%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,283.6
    -498.8 (-1.80%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,070.0
    -50.7 (-0.83%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,329.7M
  • Value: 1,564.3M
  • Rise: 137
  • Fall: 185
  • Unch: 438

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.115+0.007
Hong Lai Huat0.107+0.003
RH PetroGas0.175-0.007
Singtel2.270-0.010
Shen Yao0.006-0.001
Golden Agri-Res0.230-0.005
CapLand IntCom T2.150+0.010
Genting Sing0.810-0.010
Mercurius0.061-
GKE0.146-0.007

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 25,961.0
HSCEI 9,233.2
Jakarta 6,070.0
Nikkei 225 27,283.6
SSE Comp 3,397.4
Shanghai A 3,560.7
Shanghai B 254.0
KOSPI 3,202.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TREVI THERAPEUTICS INC TREVI THERAPEUTICS
Updated on 30 Jul 2021 (End of trading day)
Last (USD): 1.900 Change: -0.010 High: 1.955 Remarks: -
Change (%): -0.52 Low: 1.900
Open 1.900 Yesterday's Close 1.91
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 22,709 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.51885 Trailing EPS (USD) e -1.51412 NAV (USD) b 1.0982
PE a - Trailing PE f - Price / NAV b 1.7301
Dividend (USD) d - Cash In Hand (USD) g 1.9274 Issued & Paid-up Shares c 21,567,700
Dividend Yield (%) d - Price / Cash In Hand g 0.986 Treasury Shares h -
Market Cap (M) 40.979 Enterprise Value (M) 13.940
Piotroski F Score 0 Exchange Code TRVI Par Value ( $ ) n.a.
52 Weeks Volatility (%) 62.07 Free Float (%) 27.6
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Jul 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 24 Apr 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TREVI THERAPEUTICS INC NASDAQ 40.979 - - 1.7301 -
Industry Pharmaceuticals: Major NASDAQ 2,391.520 87.484 91.614 3.4041 0.026
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 177,342.685 55.061 54.624 - 2.028
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,276.652 9.281 36.392 - 2.594
Local Peer ROYALTY PHARMA PLC NASDAQ 23,191.678 23.785 23.840 4.7502 0.502
Local Peer VIATRIS INC NASDAQ 17,005.846 - - 0.7941 -
Local Peer REPLIGEN CORP NASDAQ 13,507.898 225.409 135.170 8.4263 -
Local Peer CUREVAC NV NASDAQ 9,173.197 - - - -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 7,267.207 - - 7.3797 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 6,352.760 - - 6.7328 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,223.515 - - 30.1436 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 6,009.240 88.078 88.078 6.9838 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 5,150.990 - - 99.7195 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,545.977 - - 12.3086 -
Other Local Peers ALLAKOS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), OPKO HEALTH INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), PETIQ INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), GH RESEARCH PLC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ESSA PHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ANNEXON INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), EVOLUS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), PHARVARIS NV (NASDAQ), VERU INC (NASDAQ), AC IMMUNE SA (NASDAQ), CLENE INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), BEYONDSPRING INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), DURECT CORP (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), 89BIO INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), NEXIMMUNE INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), VINCERX PHARMA INC (NASDAQ), IMMUNIC INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), OBSEVA SA (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), IMARA INC (NASDAQ), GENPREX INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), NOVAN INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), PROPHASE LABS INC (NASDAQ), GALECTO INC (NASDAQ), MEDIWOUND LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), GRAYBUG VISION INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), MANNATECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 453,313.056 30.808 25.514 6.5150 2.311
Global Peer PFIZER INC NYSE 239,637.109 24.921 18.116 - 3.554
Global Peer ELI LILLY AND COMPANY NYSE 233,522.831 37.703 38.330 33.8505 1.213
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 224,916.064 27.698 25.007 4.1619 2.086
Global Peer ABBVIE INC NYSE 205,411.386 45.086 40.403 14.9827 4.159
Global Peer MERCK & CO INC NYSE 194,639.452 27.542 48.346 - 3.224
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 164,139.056 25.472 24.416 17.7561 1.453
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 150,814.606 - - 4.0973 2.738
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 100,985.818 13.698 17.026 4.7540 5.155
Global Peer WUXI APPTEC HKEx 510,950.397 153.950 107.255 12.2061 0.203
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM (HKEx), HUTCHMED (HKEx), ORGANON & CO (NYSE), REMEGEN-B (HKEx), HYGEIA HEALTH (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), AKESO-B (HKEx), CMS (HKEx), INNOCARE-B (HKEx), BAIYUNSHAN PH (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), CHINARES PHARMA (HKEx), SIMCERE PHARMA (HKEx), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), EVEREST MED-B (HKEx), HENLIUS (HKEx), CSTONE PHARMA-B (HKEx), CARSGEN-B (HKEx), SSY GROUP (HKEx), HEPALINK (HKEx), OCUMENSION-B (HKEx), ADC THERAPEUTICS SA (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), ZYMEWORKS INC (NYSE), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), UNITED LAB (HKEx), ANTENGENE-B (HKEx), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), Kimia Farma Tbk. (IDX), CKLIFE SCIENCES (HKEx), SCICLONE PHARMA (HKEx), SHINEWAY PHARM (HKEx), ZHAOKE OPHTH-B (HKEx), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), STARPHARMA HOLDINGS LIMITED (ASX), IGBB (Bursa), PYC THERAPEUTICS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), DAWNRAYS PHARMA (HKEx), AFT PHARMACEUTICALS LTD (ASX), TOT BIOPHARM-B (HKEx), BSTEAD (Bursa), ANNOVIS BIO INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHARMA (Bursa), FUSEN PHARM (HKEx), LANNETT CO INC (NYSE), IP (SET), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), NOXOPHARM LTD (ASX), IX Biopharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), CRESO PHARMA LTD (ASX), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), NC HEALTHCARE (HKEx), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), INVION LTD (ASX), MODERN CHI MED (HKEx), BIOHLDG (Bursa), EXOPHARM LTD (ASX), NEP INTERLONG (HKEx), AGEX THERAPEUTICS INC (NYSE American), MEDLAB CLINICAL LIMITED (ASX), WAI YUEN TONG (HKEx), PALLA PHARMA LTD (ASX), TBG DIAGNOSTICS LTD (ASX), PURAPHARM (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), EXTRAWELL PHAR (HKEx), PHARMAXIS (ASX), JCT (SET), SUNZEN (Bursa), TALI DIGITAL LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), IMMURON LIMITED (ASX), ACRUX (ASX), SINOLIFE UTD (HKEx), SUDA PHARMACEUTICALS LTD (ASX), ISLAND PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.080
-4.04 %
10 Days --0.070
-3.55 %
20 Days --0.250
-11.63 %
Medium Term Return 3 Months --0.390
-17.03 %
6 Months --1.080
-36.24 %
1 Year --3.070
-61.77 %
Long Term Return 2 Years --3.090
-61.92 %
Annualised Return Annualised --
-38.29 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.780 - 8.500 Change From 1 Year Low +0.120 % Change From 1 Year Low (%) +6.74
Change From 1 Year High -6.600 % Change From 1 Year High (%) -77.65
2 Years Range 1.330 - 8.500 Change From 2 Years Low +0.570 % Change From 2 Years Low (%) +42.86
Change From 2 Years High -6.600 % Change From 2 Years High (%) -77.65
5 Years Range 1.330 - 10.620 Change From 5 Years Low +0.570 % Change From 5 Years Low (%) +42.86
Change From 5 Years High -8.720 % Change From 5 Years High (%) -82.11
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Historical Price Data

Date Open High Low Close Volume VWAP
30 Jul 2021 1.900 1.955 1.900 1.900 22,709 -
29 Jul 2021 1.910 2.020 1.900 1.910 8,428 -
28 Jul 2021 1.856 2.090 1.856 1.888 9,692 -
27 Jul 2021 1.990 1.990 1.810 1.880 21,686 -
26 Jul 2021 1.880 2.000 1.790 1.900 49,383 -
23 Jul 2021 2.011 2.086 1.950 1.980 17,849 -
22 Jul 2021 2.070 2.140 1.980 2.030 41,837 -
21 Jul 2021 1.990 2.070 1.890 2.000 49,193 -
20 Jul 2021 1.940 2.015 1.914 1.950 40,379 -
19 Jul 2021 2.030 2.030 1.870 1.930 56,587 -
16 Jul 2021 1.970 2.000 1.927 1.970 23,225 -
15 Jul 2021 2.000 2.000 1.780 1.950 62,967 -
14 Jul 2021 2.030 2.040 1.970 1.980 54,824 -
13 Jul 2021 2.030 2.090 1.960 2.020 56,010 -
12 Jul 2021 2.090 2.120 2.000 2.040 62,383 -
09 Jul 2021 2.040 2.130 2.040 2.100 30,013 -
08 Jul 2021 2.100 2.130 1.970 2.030 67,250 -
07 Jul 2021 2.150 2.170 1.970 2.150 106,348 -
06 Jul 2021 2.230 2.240 2.150 2.180 63,300 -
02 Jul 2021 2.150 2.200 2.110 2.150 106,049 -
01 Jul 2021 2.210 2.270 2.140 2.140 118,154 -
30 Jun 2021 2.190 2.310 2.160 2.250 79,137 -
Summary
Current 2 Weeks
(19 Jul 2021 to 30 Jul 2021)
2.030 2.140 1.790 1.900 317,743 -
Previous 2 Weeks
(02 Jul 2021 to 16 Jul 2021)
2.150 2.200 1.790 1.970 632,369 -
4 Weeks from
(04 Jun 2021 to 01 Jul 2021)
2.250 2.250 1.790 2.140 2,670,212 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Rev